Evidence map›Paper›PMID 29402680›Full record

Trial reportDrug and alcohol dependence2018

A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.

Lauren Brinkley-Rubinstein, Michelle McKenzie, Alexandria Macmadu, Sarah Larney, Nickolas Zaller, Emily Dauria, Josiah Rich

Erratum issued Registry-linked trialOpen access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07528846 (Justice Community Overdose Innovation Network II TCU Hub), which is not on this map. Cited by 56 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 9 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07528846 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Justice Community Overdose Innovation Network II TCU Hub: TCU Building Resilient Initiatives for Deflection Through Greater Engagement Project (TCU BRIDGE to Deflection Project)

TypeinterventionalSponsorTexas Christian UniversityRan2026 to 2029Enrolled1,620ConditionsSubstance Use Disorder (SUD), Drug Overdose, Criminal BehaviorArmsCore-interagency community engagement approach, Enhanced-Core plus community engagement specialist
3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 9 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  3. Management of opioid use disorder: 2024 update to the national clinical practice guideline.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024
    Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Interventions for female drug-using offenders.The Cochrane database of systematic reviews · 2019
    Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Article
  13. [Therapy of substance use disorders in correctional settings].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Lauren Brinkley-RubinsteinDepartment of Social Medicine, University of North Carolina, Chapel Hill, NC, United States. Electronic address: Lauren_Brinkley@med.unc.edu.
Michelle McKenzieCenter for Prisoner Health and Human Rights, The Miriam Hospital, Providence, RI, United States.
Alexandria MacmaduCenter for Prisoner Health and Human Rights, The Miriam Hospital, Providence, RI, United States.
Sarah LarneyNational Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Nickolas ZallerCollege of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
Emily DauriaDepartment of Psychiatry, University of California, San Francisco, CA, United States.
Josiah RichDivision of Infectious Diseases, The Miriam Hospital, Providence, RI, United States.
Miriam Hospital · USUniversity of Arkansas for Medical Sciences · USUniversity of California, San Francisco · USUniversity of North Carolina at Chapel Hill · USUNSW Sydney · AU

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
UCLA Implementation Science and Substance Use Research and Education (ISSURE) ProgramR25DA035692 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIMOTHY W FONG, GAIL E. WYATT · 2013 to 2026
$3.9M
The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIVR25DA037190 · NIDA · MIRIAM HOSPITAL · PI CURT G BECKWITH · 2014 to 2026
$3.5M
Midcareer Investigator Award in Patient Oriented ResearchK24DA022112 · NIDA · MIRIAM HOSPITAL · PI RICH, JOSIAH D · 2008 to 2017
$1.7M
Prisoner Overdose Training and Naloxone Upon ReleaseR21DA029201 · NIDA · MIRIAM HOSPITAL · PI RICH, JOSIAH D · 2011 to 2012
$354k
NIAID NIH HHS P30 AI042853NIDA NIH HHS K24 DA022112NIDA NIH HHS R21 DA029201NIDA NIH HHS R25 DA035692NIDA NIH HHS R25 DA037190
6 · The paper itself

Abstract

Recently, incarcerated individuals are at increased risk of opioid overdose. Methadone maintenance treatment (MMT) is an effective way to address opioid use disorder and prevent overdose; however, few jails and prisons in the United States initiate or continue people who are incarcerated on MMT. In the current study, the 12 month outcomes of a randomized control trial in which individuals were provided MMT while incarcerated at the Rhode Island Department of Corrections (RIDOC) are assessed. An as-treated analysis included a total of 179 participants-128 who were, and 51 who were not, dosed with methadone the day before they were released from the RIDOC. The results of this study demonstrate that 12 months post-release individuals who received continued access to MMT while incarcerated were less likely to report using heroin and engaging in injection drug use in the past 30 days. In addition, they reported fewer non-fatal overdoses and were more likely to be continuously engaged in treatment in the 12-month follow-up period compared to individuals who were not receiving methadone immediately prior to release. These findings indicate that providing incarcerated individuals continued access to MMT has a sustained, long-term impact on many opioid-related outcomes post-release.

Indexed as

PrisonersSubstance Withdrawal SyndromeAdultAnalgesics, OpioidFemaleFollow-Up StudiesHeroin DependenceHumansMaleMethadoneOpiate Substitution TreatmentOpioid-Related DisordersPrisonsRandom AllocationRhode IslandSubstance Abuse, IntravenousAnalgesics, OpioidMethadoneIncarcerationMethadone maintenance treatment

Identifiers

PMID29402680
PMCPMC10445765
OpenAlexW2793840464

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.